Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cerebrospinal Fluid Rhinorrhea × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1024 Neoplasms 781 Carcinoma, Non-Small-Cell Lung 762 Prostatic Neoplasms 586 Lung Neoplasms 482 Colorectal Neoplasms 479 Neoplasm Metastasis 407 Multiple Myeloma 363 Leukemia, Myeloid, Acute 355 Ovarian Neoplasms 344 Melanoma 295 Squamous Cell Carcinoma of Head and Neck 277 Recurrence 276 Pancreatic Neoplasms 274 Brain Neoplasms 242 Carcinoma, Hepatocellular 227 Glioblastoma 224 Triple Negative Breast Neoplasms 215 Stomach Neoplasms 200 Uterine Cervical Neoplasms 192 Lymphoma 191 Head and Neck Neoplasms 190 Endometrial Neoplasms 188 Carcinoma, Renal Cell 188 Precursor Cell Lymphoblastic Leukemia-Lymphoma 187 Glioma 181 Lymphoma, Non-Hodgkin 175 Sarcoma 174 Lymphoma, Large B-Cell, Diffuse 174 Leukemia, Lymphocytic, Chronic, B-Cell 170

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07539792 2026-04-20

EEEA-AMSBP

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting

Cerebrospinal Fluid Rhinorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡